Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-27T06:30:11.033Z Has data issue: false hasContentIssue false

Chapter 69 - SARS-CoV-2 Infection in Pregnancy

from Section 11 - Infectious Conditions in Pregnancy

Published online by Cambridge University Press:  23 February 2023

By
Isabelle Malhamé ,
Rohan D’Souza  and
Amira El-Messidi
Edited by
Amira El-Messidi  and
Alan D. Cameron
Amira El-Messidi
Affiliation:
McGill University, Montréal
Alan D. Cameron
Affiliation:
University of Glasgow
Get access

Summary

A 37-year-old nulligravida with a one-year history of well-controlled essential hypertension is referred to your high-risk obstetrics clinic for preconception counseling. Recent comprehensive investigations are free of end-organ dysfunction. Maintaining a healthy lifestyle, she lost weight over the past year; her body mass index (BMI) is now 31 kg/m2. She uses condoms for contraception and is adherent to long-acting nifedipine once daily; folic acid–containing prenatal vitamins were initiated last month.

Keywords

COVID-19, SARS-CoV-2 infection, coronavirus, vaccination, pregnancyCounselingComorbiditiesPhysical examinationInvestigations, laboratory derangementsPerinatal risks, complications, maternal-fetal morbidity, adverse outcomeAntepartum, intrapartum, postpartum managementBreastfeedingVertical transmission, intrauterine transmissionTreatment, pharmacologyCOVID-19 pneumonia
Type
Chapter
Information
OSCEs in Obstetrics and Maternal-Fetal Medicine
An Evidence-Based Approach
 , pp. 877 - 886
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Readings

Allotey, J, Stallings, E, Bonet, M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320.Google Scholar
Conde-Agudelo, A, Romero, R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol. 2021;S0002–9378(21)00795-X.Google Scholar
Di Mascio, D, Buca, D, Berghella, V, et al. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy. Ultrasound Obstet Gynecol. 2021;57(5):687–697.Google Scholar
D’Souza, R, Ashraf, R, Rowe, H, et al. Pregnancy and COVID-19: pharmacologic considerations. Ultrasound Obstet Gynecol. 2021;57(2):195–203.CrossRefGoogle ScholarPubMed
Galang, RR, Newton, SM, Woodworth, KR, et al. Risk factors for illness severity among pregnant women with confirmed severe acute respiratory syndrome coronavirus 2 infection – surveillance for emerging threats to mothers and babies network, 22 state, local, and territorial health departments, 29 March 2020–5 March 2021. Clin Infect Dis. 2021;73(Suppl 1):S17–S23.CrossRefGoogle ScholarPubMed
Moore, KM, Suthar, MS. Comprehensive analysis of COVID-19 during pregnancy. Biochem Biophys Res Commun. 2021;538:180–186.Google Scholar
Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) infection in pregnancy; Version 14, August 25, 2021. Available at www.rcog.org.uk/coronavirus-pregnancy. Accessed September 25, 2021.Google Scholar
Shimabukuro, TT, Kim, SY, Myers, TR, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021;384(24):2273–2282. [Correction in N Engl J Med. 2021 Sep 8]CrossRefGoogle ScholarPubMed
(a)SMFM – Coronavirus (COVID-19) and pregnancy: what maternal-fetal medicine subspecialists need to know; November 23, 2020. Available at www.smfm.org/covidclinical. Accessed September 25, 2021.Google Scholar
SMFM – Management considerations for pregnant women with COVID-19; February 2, 2021. Available at at www.smfm.org/covidclinical. Accessed September 25, 2021.Google Scholar
SMFM – Provider considerations for engaging in COVID-19 vaccine counseling with pregnant and lactating patients; September 24, 2021. Available at https://www.smfm.org/covidclinical. Accessed September 25, 2021.Google Scholar
Wei, SQ, Bilodeau-Bertrand, M, Liu, S, et al. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021;193(16):E540–E548.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×